These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3758141)

  • 1. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.
    Dyckner T; Wester PO; Widman L
    Eur J Clin Pharmacol; 1986; 30(5):535-40. PubMed ID: 3758141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal excretion of electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure.
    Dyckner T; Wester PO
    Acta Med Scand; 1985; 218(5):443-8. PubMed ID: 4091044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular magnesium loss after diuretic administration.
    Dyckner T; Wester PO
    Drugs; 1984 Oct; 28 Suppl 1():161-6. PubMed ID: 6499698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of peroral magnesium on plasma and skeletal muscle electrolytes in patients on long-term diuretic therapy.
    Dyckner T; Wester PO; Widman L
    Int J Cardiol; 1988 Apr; 19(1):81-7. PubMed ID: 3372076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and skeletal muscle electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure.
    Dyckner T; Wester PO
    Acta Med Scand; 1987; 222(3):231-6. PubMed ID: 3425378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diuretics in the treatment of patients who present congestive heart failure and hypertension.
    Reyes AJ
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S104-13. PubMed ID: 11986906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of triamterene on serum and skeletal muscle electrolytes in diuretic-treated patients.
    Widmann L; Dyckner T; Wester PO
    Eur J Clin Pharmacol; 1988; 33(6):577-9. PubMed ID: 3366161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).
    Am J Cardiol; 1996 Oct; 78(8):902-7. PubMed ID: 8888663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiloride prevents thiazide-induced intracellular potassium and magnesium losses.
    Dyckner T; Wester PO; Widman L
    Acta Med Scand; 1988; 224(1):25-30. PubMed ID: 3414406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of magnesium on blood pressure.
    Dyckner T; Wester PO
    Br Med J (Clin Res Ed); 1983 Jun; 286(6381):1847-9. PubMed ID: 6407598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diuretic therapy in congestive heart failure--new views on spironolactone therapy].
    Haller C
    Ther Umsch; 2000 Jun; 57(6):374-9. PubMed ID: 10894022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of moduretic and aldactone on electrolytes in skeletal muscle in patients on long-term diuretic therapy.
    Widman L; Dyckner T; Wester PO
    Acta Med Scand Suppl; 1982; 661():33-5. PubMed ID: 6959477
    [No Abstract]   [Full Text] [Related]  

  • 13. Peroral glucose tolerance test. Relation to skeletal muscle electrolytes.
    Dyckner T; Wester PO
    Acta Med Scand; 1986; 220(4):315-9. PubMed ID: 3799238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spironolactone in the management of congestive heart failure.
    Muller JE
    Am J Cardiol; 1990 Jun; 65(23):51K-53K. PubMed ID: 2353671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure.
    Shah KB; Rao K; Sawyer R; Gottlieb SS
    J Am Coll Cardiol; 2005 Sep; 46(5):845-9. PubMed ID: 16139135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
    Verho M; Bückert C; Freude J; Jaeger S; Pahnke K
    Pharmatherapeutica; 1985; 4(5):288-95. PubMed ID: 3906674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics.
    Dørup I; Skajaa K; Clausen T; Kjeldsen K
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):455-8. PubMed ID: 2450616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of furosemide and a combination of spironolactone and hydrochlorothiazide in congestive heart failure.
    Levy B
    J Clin Pharmacol; 1977 Jul; 17(7):420-30. PubMed ID: 328540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.